We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cytokine Identified that Reduces Autoimmune Response

By Biotechdaily staff writers
Posted on 12 Dec 2003
Researchers studying the biochemical triggers that activate the immune response have found that the IL-27 cytokine may actually suppress CD4 T cells, the helper T-cells that coordinate the immune system response to infections.

Investigators at the University of Pennsylvania (Philadelphia, USA) genetically engineered a line of mice lacking the IL-27 receptor protein WSX-1. More...
These animals were infected with the intracellular pathogen Toxoplasma gondii. Results of the study published in the November 2003 issue of Immunity showed that the mice established protective T-cell responses, characterized by production of inflammatory cytokines and control of parasite replication.

However, infected mice lacking WSX-1 were unable to down regulate these protective responses and developed a lethal, T-cell-mediated inflammatory disease. The autoimmune pathology was characterized by the excessive production of gamma interferon, persistence of highly activated T-cells, and enhanced T-cell proliferation.

"There are many immune-mediated diseases with many different causes, but this particular pathway may represent a universal checkpoint for the immune system,” explained senior author Dr. Christopher Hunter, associate professor of pathobiology at the University of Pennsylvania. "It may be possible to create drugs that turn the immune system off without actually suppressing the beneficial immune reactions.”




Related Links:
University of Pennsylvania

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.